This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Upsher Smith Laboratories, Inc.. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Title: **The Innovative Journey of Sean B. Mahoney**
Introduction
Sean B. Mahoney, an accomplished inventor based in Plymouth, Minnesota, has made significant contributions to the field of pharmaceuticals. With two patents to his name, Mahoney's work has the potential to impact the healthcare industry through innovative drug delivery systems.
Latest Patents
Among his latest patents is a sustained-release product that combines a non-opioid amine with a non-steroidal anti-inflammatory drug (NSAID). This patent details oral pharmaceutical compositions and methods of use that enable these compositions to be administered in a single dosage form. This invention includes an amine-containing compound, along with a salt of an NSAID and a hydrophilic matrix. This innovative strategy aims to enhance the therapeutic effects while ensuring patient safety.
Career Highlights
Sean B. Mahoney is currently associated with Upsher Smith Laboratories, Inc., where he plays a pivotal role in the development of advanced pharmaceutical solutions. His expertise and dedication to innovation in drug formulations are evident in the patents he has secured and the research he continues to pursue.
Collaborations
Throughout his career, Mahoney has collaborated with several professionals, including notable coworkers Christian F. Wertz and James S. Jensen. These collaborations have undoubtedly contributed to the successful development of his patented technologies.
Conclusion
Sean B. Mahoney's innovative contributions and patent achievements underscore his commitment to advancing pharmaceutical research. As the industry evolves, his work stands as a testament to the critical role of inventors in shaping the future of healthcare and improving patient treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
